APA (7th ed.) Citation

R, K., S, S., J, R., S, H., B, S., & JS, B. (2025). Innovations and Best Practices for Therapeutic Development in Pediatric Rare Diseases: A Model-Informed Drug Development Perspective. Clinical pharmacology and therapeutics, 118(6), 1276. https://doi.org/10.1002/cpt.3683

Chicago Style (17th ed.) Citation

R, Krishna, Suryawanshi S, Rascher J, Hartmann S, Sebastien B, and Barrett JS. "Innovations and Best Practices for Therapeutic Development in Pediatric Rare Diseases: A Model-Informed Drug Development Perspective." Clinical Pharmacology and Therapeutics 118, no. 6 (2025): 1276. https://doi.org/10.1002/cpt.3683.

MLA (9th ed.) Citation

R, Krishna, et al. "Innovations and Best Practices for Therapeutic Development in Pediatric Rare Diseases: A Model-Informed Drug Development Perspective." Clinical Pharmacology and Therapeutics, vol. 118, no. 6, 2025, p. 1276, https://doi.org/10.1002/cpt.3683.